Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PPARGC1A: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
PPARGC1A is a gene implicated in neurodegeneration research. Key relationships include: regulates, associated with, activates. Associated with ALS, Als, Alzheimer's disease. Connected to 505 entities in the SciDEX knowledge graph.
| Gene Symbol | PPARGC1A |
| Full Name | PPARG Coactivator 1 Alpha |
| Chromosome | 4p15.31 |
| Protein Type | Transcription Factor |
| Target Class | Transcription Factor |
| Function | PPARGC1A encodes PGC-1α (PPAR gamma coactivator 1-alpha), a transcriptional coactivator that serves as a master regulator of mitochondrial biogenesis and cellular energy metabolism. |
| Mechanism of Action | Small molecule modulator of transcriptional coactivator function |
| Primary Expression | tissues with high metabolic demand: - Brain: Neurons (especially in substantia nigra, hippocampus), [astrocytes](/entities/as |
| Druggability | Low (0.43) |
| Clinical Stage | Approved |
| Pathways | Apoptosis, Autophagy, Cell Cycle, Er Stress, Ferroptosis |
| UniProt ID | Q9UBX2 |
| NCBI Gene ID | 10891 |
| Ensembl ID | ENSG00000109819 |
| OMIM | 604517 |
| GeneCards | PPARGC1A |
| Human Protein Atlas | PPARGC1A |
| Associated Diseases | ALS, Alzheimer's disease, Amyotrophic Lateral Sclerosis, Ataxia, CANCER |
| Known Drugs/Compounds | reactive oxygen species, THYROID_HORMONE, Aloe-emodin, Kaixinsan, glitazones, piperine |
| Interactions | PRKAA1, ATG10, SIRT1, DNM1L, BAX, LC3 |
| SciDEX Target | View Target Profile (8 clinical trials) |
| SciDEX Hypotheses | Perforant Path Presynaptic Terminal Protection Str PGC1α Activation in PV+ Interneurons Bypasses Mito |
| KG Connections | 992 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
PPARGC1A["PPARGC1A"] -->|"associated"| neurodegeneration["neurodegeneration"]
PPARGC1A["PPARGC1A"] -->|"interacts"| PRKAA1["PRKAA1"]
PPARGC1A["PPARGC1A"] -->|"co discussed"| SLC16A2["SLC16A2"]
PPARGC1A["PPARGC1A"] -->|"co discussed"| RELN["RELN"]
PPARGC1A["PPARGC1A"] -->|"co discussed"| MAP6["MAP6"]
PPARGC1A["PPARGC1A"] -->|"co discussed"| HCN1["HCN1"]
PRKAA1_1["PRKAA1"] -->|"interacts"| PPARGC1A["PPARGC1A"]
FOXP3["FOXP3"] -->|"co discussed"| PPARGC1A["PPARGC1A"]
TNFA["TNFA"] -->|"co discussed"| PPARGC1A["PPARGC1A"]
style PPARGC1A fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| PGC1A | encodes | protein | 0.95 |
| Mitochondrial Biogenesis | regulates | process | 0.95 |
| Mitochondrial Biogenesis | mediates | process | 0.95 |
| Parvalbumin Interneuron Maturation | mediates | process | 0.95 |
| Mitochondrial Biogenesis | involved_in | process | 0.95 |
| BACE1 | regulates | gene | 0.95 |
| mitochondrial biogenesis | promotes | process | 0.95 |
| Oxidative Phosphorylation | mediates | pathway | 0.95 |
| Alzheimer'S Disease | downregulates | disease | 0.95 |
| SQSTM1 | regulates | protein | 0.90 |
| autophagy | activates | pathway | 0.90 |
| mitochondrial biogenesis | regulates | pathway | 0.90 |
| abdominal aortic aneurysm | protects_against | disease | 0.90 |
| PPARA | activates | gene | 0.90 |
| PPARD | activates | gene | 0.90 |
| kynurenine aminotransferases | contributes_to | protein | 0.90 |
| depression | protects_against | disease | 0.90 |
| fatty acid oxidation | associated_with | pathway | 0.90 |
| lipid droplet accumulation | inhibits | phenotype | 0.90 |
| oxidative phosphorylation | associated_with | pathway | 0.90 |
| ATP production | contributes_to | pathway | 0.90 |
| cancer metastasis | associated_with | disease | 0.90 |
| Mitochondrial Biogenesis | activates | process | 0.90 |
| Reactive Oxygen Species Synthesis | regulates | process | 0.90 |
| Inflammatory Cytokines | regulates | process | 0.90 |
| NRF2 | activates | protein | 0.90 |
| Cancer Cell Invasion | contributes_to | phenotype | 0.90 |
| Pv+ Interneuron | regulates | cell_type | 0.90 |
| Parvalbumin interneuron electrophysiological properties | drives | phenotype | 0.90 |
| Parvalbumin interneuron structural development | promotes | phenotype | 0.90 |
| amyloid-beta | inhibits | protein | 0.90 |
| senescence | inhibits | phenotype | 0.90 |
| lipid metabolism | regulates | pathway | 0.90 |
| Reactive Oxygen Species | regulates | process | 0.90 |
| Metastasis | contributes_to | process | 0.90 |
| Amyloid-Beta | downregulates | protein | 0.90 |
| Alzheimer's Disease | therapeutic_target | disease | 0.90 |
| Mitochondrial Pool | associated_with | phenotype | 0.85 |
| WNT/β-Catenin Signaling | inhibits | pathway | 0.85 |
| Hepatocellular Carcinoma Progression | inhibits | disease | 0.85 |
| Structural Maturation | promotes | phenotype | 0.85 |
| Electrophysiological Maturation | promotes | phenotype | 0.85 |
| Synaptic Maturation | promotes | phenotype | 0.85 |
| Metabolic Maturation | promotes | phenotype | 0.85 |
| Terminal Differentiation | involved_in | process | 0.85 |
| Electrophysiological Properties | regulates | phenotype | 0.85 |
| Synaptic Function | regulates | phenotype | 0.85 |
| Metabolic Features | regulates | phenotype | 0.85 |
| Structural Properties | regulates | phenotype | 0.85 |
| NRF | interacts_with | protein | 0.85 |
| Source | Relation | Type | Str |
|---|---|---|---|
| IRE1A | degrades | protein | 0.95 |
| SIRT1 | interacts_with | protein | 0.90 |
| SIRT1 | modifies | protein | 0.90 |
| TFEB | activates | gene | 0.90 |
| Neuronal activity | activates | process | 0.90 |
| h-76888762 | targets_gene | hypothesis | 0.90 |
| h-b0cda336 | targets_gene | hypothesis | 0.90 |
| h-4c3210de | targets_gene | hypothesis | 0.90 |
| TFEB | upregulates | protein | 0.85 |
| CLU | associated_with | protein | 0.85 |
| ASPSCR1 | binds | protein | 0.85 |
| CREB1 | upregulates | gene | 0.85 |
| PRKAA2 | activates | gene | 0.85 |
| METTL3 | downregulates | gene | 0.85 |
| WTAP | downregulates | gene | 0.85 |
| exercise | activates | phenotype | 0.80 |
| h-76888762 | targets | hypothesis | 0.80 |
| h-b0cda336 | targets | hypothesis | 0.80 |
| Metformin | upregulates | drug | 0.80 |
| Prkaa2 | activates | protein | 0.80 |
| aging | inhibits | phenotype | 0.80 |
| IRE1A | inhibits | gene | 0.72 |
| ACTB | regulates | gene | 0.70 |
| CAT | regulates | gene | 0.70 |
| CTSD | regulates | gene | 0.70 |
| SQSTM1 | associated_with | gene | 0.70 |
| P62 | associated_with | gene | 0.70 |
| Aloe-emodin | activates | drug | 0.70 |
| Kaixinsan | activates | drug | 0.70 |
| amyloid beta | inhibits | protein | 0.70 |
| PPARG | regulates | protein | 0.70 |
| PPARγ | activates | protein | 0.70 |
| glitazones | activates | drug | 0.70 |
| piperine | activates | drug | 0.70 |
| GLP-1 | regulates | protein | 0.70 |
| Lactiplantibacillus plantarum SG5 | activates | drug | 0.70 |
| AMPK | regulates | protein | 0.70 |
| FBXW7 | inhibits | gene | 0.70 |
| MPTP | inhibits | drug | 0.70 |
| MITOCHONDRIA | activates | gene | 0.70 |
| CANCER | regulates | gene | 0.70 |
| ATG | activates | gene | 0.70 |
| rapamycin | targets | drug | 0.70 |
| metformin | targets | drug | 0.70 |
| TFEB | regulates | gene | 0.64 |
| CLU | interacts_with | gene | 0.64 |
| THYROID_HORMONE | activates | drug | 0.64 |
| METTL3 | inhibits | gene | 0.64 |
| WTAP | inhibits | gene | 0.64 |
| METFORMIN | activates | drug | 0.64 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Perforant Path Presynaptic Terminal Protection Strategy | 0.484 | neurodegeneration | Selective vulnerability of entorhinal co |
| PGC1α Activation in PV+ Interneurons Bypasses Mitophagy Defi | 0.455 | neurodegeneration | Why does PRKN-mediated mitophagy, typica |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-03 | 17 hypotheses Top: 0.662
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.605
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.484
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| A postnatal molecular switch drives activity-dependent maturation of parvalbumin [PMID:40669459] | Moissidis M, Abbasova L, Selten M, Alis | Cell | 2025 | 1 |
| The Role of PGC1α in Alzheimer's Disease and Therapeutic Interventions. [PMID:34071270] | Mota BC, Sastre M | Int J Mol Sci | 2021 | 1 |
| Insulin-stimulated endoproteolytic TUG cleavage links energy expenditure with gl [PMID:33686286] | Habtemichael EN, Li DT, Camporez JP, Wes | Nat Metab | 2021 | 1 |
| Metabolic effects of RUBCN/Rubicon deficiency in kidney proximal tubular epithel [PMID:31944172] | Matsuda J, Takahashi A, Takabatake Y, Sa | Autophagy | 2020 | 1 |
| Minutes of PPAR-γ agonism and neuroprotection. [PMID:32758586] | Prashantha Kumar BR, Kumar AP, Jose JA, | Neurochem Int | 2020 | 1 |
| Polystyrene microplastics induced spermatogenesis disorder via disrupting mitoch [PMID:39577614] | ["Jin H", "Xue B", "Chen X", "Ma T", "Ma | Environmental pollution (Barki | 2025 | 0 |
| Lipidomic and Transcriptomic Reveals Variations in Lipid Deposition During Goose [PMID:41300406] | Zhang Q, Bai C, Zhang M, Yue B, Zhang J, | Biology | 2025 | 0 |
| Blueberry anthocyanins ameliorate arsenic-induced cognitive impairment in rats: [PMID:40663938] | Ma X, Liu Y, Ding B, Liu Y, Zhang Y, Wan | Phytomedicine : international | 2025 | 0 |
| Deciphering the PGC-1α-TFAM Axis in Parkinson's Disease (PD) - A Mechanism Appro [PMID:41454214] | Iyer M, Kinoshita M, Reddy DH, Babu HWS, | Molecular neurobiology | 2025 | 0 |
| Cardioprotective effects of the jiming formula on myocardial metabolism in Mice [PMID:40220403] | Fan X, Wei X, Wang W, Chai W, Xiao J, Ha | Phytomedicine : international | 2025 | 0 |
| Tang Bi formula alleviates diabetic sciatic neuropathy via AMPK/PGC-1α/MFN2 path [PMID:40646155] | ["Yang C", "Yu H", "Zhou L", "Su H", "Li | Scientific reports | 2025 | 0 |
| Tetramethylpyrazine nitrone exerts neuroprotection via activation of PGC-1α/Nrf2 [PMID:37989471] | ["Guo B", "Zheng C", "Cao J", "Luo F", " | Journal of advanced research | 2024 | 0 |
| Alcohol-related breast cancer in postmenopausal women - effect of CYP19A1, PPARG [PMID:27102200] | ["Kopp T", "Jensen D", "Ravn-Haren G", " | BMC cancer | 2016 | 0 |
| Effect of rosiglitazone on peroxisome proliferator-activated receptor gamma gene [PMID:18954260] | ["Mallon P", "Sedwell R", "Rogers G", "N | The Journal of infectious dise | 2008 | 0 |